These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31890472)

  • 1. Varicella-zoster virus post-exposure management and prophylaxis: A review.
    Lachiewicz AM; Srinivas ML
    Prev Med Rep; 2019 Dec; 16():101016. PubMed ID: 31890472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varicella zoster immune globulin (human) (VARIZIG) in immunocompromised patients: a subgroup analysis for safety and outcomes from a large, expanded-access program.
    Gans H; Chemaly RF
    BMC Infect Dis; 2021 Jan; 21(1):46. PubMed ID: 33430796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: Hospital-acquired chickenpox in a healthcare setting.
    Utpat S; Utpat N; Nookala V; Podakula L; Utpat K
    Epidemiol Infect; 2023 Dec; 152():e3. PubMed ID: 38112097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: Varicella outcomes and safety results from a large, open-label, expanded-access program.
    Levin MJ; Duchon JM; Swamy GK; Gershon AA
    PLoS One; 2019; 14(7):e0217749. PubMed ID: 31269033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myths and Misconceptions: Varicella-Zoster Virus Exposure, Infection Risks, Complications, and Treatments.
    Newman AM; Jhaveri R
    Clin Ther; 2019 Sep; 41(9):1816-1822. PubMed ID: 31326126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.
    Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Varicella Outcomes in In Utero-Exposed Newborns and Preterm Infants Treated With Varicella Zoster Immune Globulin (VARIZIG): A Subgroup Analysis of an Expanded-Access Program.
    Duchon JM; Levin MJ; Gershon AA
    J Pediatric Infect Dis Soc; 2020 Sep; 9(4):449-453. PubMed ID: 31774916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updated recommendations for use of VariZIG--United States, 2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Jul; 62(28):574-6. PubMed ID: 23863705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA approval of an extended period for administering VariZIG for postexposure prophylaxis of varicella.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Mar; 61(12):212. PubMed ID: 22456121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicella-zoster virus.
    Arvin AM
    Clin Microbiol Rev; 1996 Jul; 9(3):361-81. PubMed ID: 8809466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines for preventing herpes zoster in older adults.
    de Oliveira Gomes J; Gagliardi AM; Andriolo BN; Torloni MR; Andriolo RB; Puga MEDS; Canteiro Cruz E
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD008858. PubMed ID: 37781954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes Zoster Recurrence: A Narrative Review of the Literature.
    Parikh R; Spence O; Giannelos N; Kaan I
    Dermatol Ther (Heidelb); 2024 Mar; 14(3):569-592. PubMed ID: 38416279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Herpes Zoster Following Varicella Vaccination in Immunocompetent Young Children.
    Moodley A; Swanson J; Grose C; Bonthius DJ
    J Child Neurol; 2019 Mar; 34(4):184-188. PubMed ID: 30628536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of varicella (VZV) vaccination: an update for the clinician.
    Wang L; Zhu L; Zhu H
    Ther Adv Vaccines; 2016 Jan; 4(1-2):20-31. PubMed ID: 27551429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Routine Varicella Immunization on the Epidemiology and Immunogenicity of Varicella and Shingles.
    Otani N; Shima M; Yamamoto T; Okuno T
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project data.
    Goldman GS; King PG
    Hum Exp Toxicol; 2014 Aug; 33(8):886-93. PubMed ID: 24275643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunization of adults against varicella and herpes zoster].
    Hanslik T; Blanchon T; Alvarez FP
    Rev Med Interne; 2007 Mar; 28(3):166-72. PubMed ID: 17270316
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Patil A; Goldust M; Wollina U
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines for preventing herpes zoster in older adults.
    Gagliardi AM; Andriolo BN; Torloni MR; Soares BG; de Oliveira Gomes J; Andriolo RB; Canteiro Cruz E
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31696946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.